(NRIM) Northrim BanCorp - Ratings and Ratios
Commercial Banking, Mortgage Services, Wealth Management
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.84% |
| Yield on Cost 5y | 28.85% |
| Yield CAGR 5y | 8.52% |
| Payout Consistency | 98.4% |
| Payout Ratio | 8.8% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 34.9% |
| Value at Risk 5%th | 53.3% |
| Relative Tail Risk | -7.20% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.30 |
| Alpha | 40.55 |
| CAGR/Max DD | 0.93 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.605 |
| Beta | 0.722 |
| Beta Downside | 0.747 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.27% |
| Mean DD | 11.21% |
| Median DD | 10.06% |
Description: NRIM Northrim BanCorp December 27, 2025
Northrim BanCorp Inc. (NASDAQ:NRIM) is a Alaska-based bank holding company that serves businesses and professionals through three operating segments: Community Banking, Home Mortgage Lending, and Specialty Finance. Its product suite spans non-interest-bearing checking, interest-bearing deposits, certificates of deposit, and a full range of commercial and consumer loan products, complemented by a digital banking platform offering online account opening, mobile deposits, and a suite of cash-management tools.
As of Q3 2024, the bank reported a net interest margin of 3.4% and a loan-to-deposit ratio of 78%, both modestly above the regional-bank average, reflecting steady loan growth (≈5% YoY) amid a tightening credit environment. The company’s performance is closely tied to Alaska’s economic backdrop-particularly oil-price volatility and seasonal tourism-which drives both commercial loan demand and deposit inflows. Additionally, the broader regional-bank sector is navigating the Federal Reserve’s higher-for-longer rate policy, which can boost NIM but also pressures credit quality.
For a deeper quantitative view, consider checking ValueRay’s platform for detailed financial metrics and peer comparisons.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (63.1m TTM) > 0 and > 6% of Revenue (6% = 14.1m TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA 4.07pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -921.8% (prev -1064 %; Δ 142.7pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.04 (>3.0%) and CFO 140.3m > Net Income 63.1m (YES >=105%, WARN >=100%) |
| Net Debt (-182.9m) to EBITDA (84.3m) ratio: -2.17 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.25 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (22.5m) change vs 12m ago 0.60% (target <= -2.0% for YES) |
| Gross Margin 80.20% (prev 77.14%; Δ 3.06pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 7.49% (prev 6.19%; Δ 1.30pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.89 (EBITDA TTM 84.3m / Interest Expense TTM 43.0m) >= 6 (WARN >= 3) |
Altman Z'' -3.71
| (A) -0.65 = (Total Current Assets 739.9m - Total Current Liabilities 2.91b) / Total Assets 3.31b |
| (B) 0.09 = Retained Earnings (Balance) 300.7m / Total Assets 3.31b |
| (C) 0.03 = EBIT TTM 81.2m / Avg Total Assets 3.14b |
| (D) 0.10 = Book Value of Equity 305.5m / Total Liabilities 3.00b |
| Total Rating: -3.71 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 85.77
| 1. Piotroski 5.0pt |
| 2. FCF Yield data missing |
| 3. FCF Margin 58.75% |
| 4. Debt/Equity 0.09 |
| 5. Debt/Ebitda -2.17 |
| 6. ROIC - WACC (= 10.00)% |
| 7. RoE 21.89% |
| 8. Rev. Trend 98.35% |
| 9. EPS Trend 31.50% |
What is the price of NRIM shares?
Over the past week, the price has changed by +2.76%, over one month by +5.31%, over three months by +38.31% and over the past year by +54.44%.
Is NRIM a buy, sell or hold?
- Strong Buy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the NRIM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 31.5 | 13.1% |
| Analysts Target Price | 31.5 | 13.1% |
| ValueRay Target Price | 39 | 40.1% |
NRIM Fundamental Data Overview January 14, 2026
P/E Forward = 12.7714
P/S = 3.0394
P/B = 1.9721
Revenue TTM = 235.0m USD
EBIT TTM = 81.2m USD
EBITDA TTM = 84.3m USD
Long Term Debt = 23.2m USD (from longTermDebt, last quarter)
Short Term Debt = 6.56m USD (from shortTermDebt, last quarter)
Debt = 29.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -182.9m USD (from netDebt column, last quarter)
Enterprise Value = 10.5m USD (612.6m + Debt 29.8m - CCE 631.9m)
Interest Coverage Ratio = 1.89 (Ebit TTM 81.2m / Interest Expense TTM 43.0m)
EV/FCF = 0.08x (Enterprise Value 10.5m / FCF TTM 138.1m)
FCF Yield = 1316 % (FCF TTM 138.1m / Enterprise Value 10.5m)
FCF Margin = 58.75% (FCF TTM 138.1m / Revenue TTM 235.0m)
Net Margin = 26.85% (Net Income TTM 63.1m / Revenue TTM 235.0m)
Gross Margin = 80.20% ((Revenue TTM 235.0m - Cost of Revenue TTM 46.5m) / Revenue TTM)
Gross Margin QoQ = 80.40% (prev 78.54%)
Tobins Q-Ratio = 0.00 (Enterprise Value 10.5m / Total Assets 3.31b)
Interest Expense / Debt = 35.70% (Interest Expense 10.6m / Debt 29.8m)
Taxrate = 21.71% (7.50m / 34.6m)
NOPAT = 63.6m (EBIT 81.2m * (1 - 21.71%))
Current Ratio = 0.25 (Total Current Assets 739.9m / Total Current Liabilities 2.91b)
Debt / Equity = 0.09 (Debt 29.8m / totalStockholderEquity, last quarter 315.7m)
Debt / EBITDA = -2.17 (Net Debt -182.9m / EBITDA 84.3m)
Debt / FCF = -1.32 (Net Debt -182.9m / FCF TTM 138.1m)
Total Stockholder Equity = 288.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.01% (Net Income 63.1m / Total Assets 3.31b)
RoE = 21.89% (Net Income TTM 63.1m / Total Stockholder Equity 288.2m)
RoCE = 26.08% (EBIT 81.2m / Capital Employed (Equity 288.2m + L.T.Debt 23.2m))
RoIC = 19.47% (NOPAT 63.6m / Invested Capital 326.5m)
WACC = 9.47% (E(612.6m)/V(642.4m) * Re(8.57%) + D(29.8m)/V(642.4m) * Rd(35.70%) * (1-Tc(0.22)))
Discount Rate = 8.57% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.35%
[DCF Debug] Terminal Value 63.88% ; FCFF base≈84.1m ; Y1≈55.2m ; Y5≈25.2m
Fair Price DCF = 26.06 (EV 392.8m - Net Debt -182.9m = Equity 575.7m / Shares 22.1m; r=9.47% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 31.50 | EPS CAGR: -15.12% | SUE: -4.0 | # QB: 0
Revenue Correlation: 98.35 | Revenue CAGR: 19.75% | SUE: 0.81 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.62 | Chg30d=+0.090 | Revisions Net=+2 | Analysts=2
EPS next Year (2026-12-31): EPS=2.81 | Chg30d=+0.400 | Revisions Net=+2 | Growth EPS=+12.4% | Growth Revenue=+11.6%
Additional Sources for NRIM Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle